Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Last Updated:
Coronavirus Infection More Likely To Cause Blood Clots Than Vaccines: New Oxford Study
The latest study by Oxford University says that the rare blood clot is caused majorly by Coronavirus infection & the risk post-vaccine is lesser than the virus.
Credits: OXFORD/TWITTER/AP/UNSPLASH/REPRESENTATIVE IMAGE
The University of Oxford has published its latest findings on rare blood clot risks which are caused post-COVID-19 infection and it is much more severe than the post-vaccine effect. The study shows that the rare blood clot is 100 times more harmful than normal and several times more dangerous than after vaccination. The rare blood clot is found to be Cerebral Venous Thrombosis (CVT) which is common following the infection. The under-30 age group has seen 30 per cent of such cases.
Follow RT on A potentially fatal blood-clotting disease is 30 times more common among people who have received the Covid-19 vaccines produced by Moderna and Pfizer than those given the troubled AstraZeneca jab, researchers have found.
A team of scientists from the University of Oxford has found that after vaccination, Vaxzevria (formerly AstraZeneca Covid-19 vaccine) recipients were less likely to suffer portal vein thrombosis (PVT) – blood clots in the artery from the intestines to the liver.
For recipients of the viral vector Vaxzevria vaccine, the incidence rate for splanchnic thrombosis – clotting in the portal and other abdominal veins – is 1.6 per million people, according to data from the EU drugs regulator the European Medicines Agency (EMA). By contrast, some 44.9 cases of PVT per million people were seen among those who had been injected with the mRNA vaccines made by Moderna and Pfizer, the Oxford research, published on Thursday, said.
Rare blood clotting risk more for COVID-19 than for vaccines: Oxford study
Rare blood clotting risk more for COVID-19 than for vaccines: Oxford study
After contracting Covid-19 the risk of blood clotting is much greater than it is post immunisation according to Oxford University study.
advertisement
(Representative image: Reuters)
The risk of rare blood clotting following the Covid-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.
The research found that the rare blood clotting known as Cerebral Venous Thrombosis (CVT) is more common after Covid-19 than in any of the comparison groups, with 30 per cent of these cases occurring in the under 30s.
The scientists of the University of Oxford say Covid-19 leads to a risk of rare blood clots that’s higher than that of current vaccines, amid concerns that the jabs may be to blame for the potentially deadly condition.
A report released by the institution on Thursday states that the risk of the rare condition known as cerebral venous thrombosis (CVT) following Covid-19 infection is “around 100 times greater than normal” and “several times higher” than it is post-vaccination or after flu.